This report contains a summary of the data compiled during the evaluation of the test compound. The report is organized to present the results in a concise and easily interpretable manner. The first part contains items I-IX. Items I-IV provides sponsor and compound identification information, type of assay, and the assay design reference number. All assay design references indicate a standard procedure described in the Litton Bionetics, Inc. 'Screening Program for the Identification of Potential Mutagens and Carcinogens.' Item V provides the initiation and completion dates for the study, and Item VI provides identification of supervisory personnel. Item VII identifies the tables and figures containing the data used by the study director in interpreting the test results. The interpretation itself is in Item VIII. Item IX provides the conclusion and evaluation. The second part of the report, entitled Assay Design, describes the materials and procedures employed in conducting the assay. This part of the report also contains evaluation criteria used by the study director, and any appendices. The evaluation criteria are included to acquaint the sponsor with the methods used to develop and analyze the test results.